QUEST: Chinese Herbal Medicine (Qiliqiangxin) reduces heart failure hospitalizations and cardiovascular mortality in HFrEF
Key Points: Qiliqiangxin is a traditional Chinese herbal medicine extract which has…
STEP-HFpEF: Semaglutide reduces heart failure symptoms and body weight in HFpEF patients at one year
Key Points: More than 80% of patients with HFpEF are overweight or…
COP-AF: Colchicine did not reduce AF or myocardial injury after non-cardiac surgery, but post-hoc analysis suggest benefit in composite outcomes
Key Points This trial randomizing patients aged 55 or older to colchicine…
NOAH-AFNET 6: No benefit of oral anticoagulation among patients with atrial high-rate episodes in the absence of confirmed AF
Key Points This trial randomized elderly patients without a known diagnosis of…
HOST-IDEA: 3-Month DAPT Noninferior to 12-Month DAPT in Patients Undergoing PCI using third-generation stents
Key Points: Among patients undergoing PCI using third-generation DES with ultrathin struts…
UK Biobank Analysis: Self-reported LCHF Diet May be Linked to Cardiac Events
Key Points: In spite of the increase popularity of low-carbohydrate high-fat diet…
hsCRP is a Stronger Predictor of CV Events and Death than LDL-C in High-Risk Patients on Statins
Key Points: Both inflammatory risk and hyperlipidemia and crucial risk factors for…
FREEDOM COVID: Therapeutic dose anticoagulation does not reduce MACE in non-critically ill COVID-19 patients
Key Points: There have been conflicting data on the role and recommended…
STELLAR: Sotatercept improves 6MWD in PAH patients and WHO FC II-III
Key Points: Sotatercept is a novel activin signaling inhibitor which was designed…
Dapagliflozin Reduces PCWP at Rest and Exercise, Plasma Volume, and Weight in HFpEF patients
Key Points: SGLT2i therapy reduces HF hospitalizations and CV mortality in HFpEF,…
BMAD Trial: Use of data from μCor, A Novel Wearable Sensor, reduces HF readmissions following a recent HF hospitalization
Key Points: The μCor monitor is a novel device that uses…
A Novel, Oral, PSCK-9 Inhibitor Showed Significant and Dose-dependent Reduction of LDL compared to Placebo
Key Points -Lowering LDL-C is known to reduce the risk of ASCVD…
LIVE HCM Trial: Vigorous Exercise in Patients with HCM Not Associated with Increased Risk of Adverse Cardiac Events
Key Points -HCM is the most common cause of sudden cardiac death…
The future is now: A wrist-worn Sensor Coupled with AI Accurately Predicts Troponin Elevation in ACS Patients
Key Points - Prompt identification of patients suffering from ACS requires measurements…
Low Cardiac Risk for Elite Level Athletes With Genetic Heart Disease
Key Points -Patients with diagnosed sudden cardiac death (SCD)-predisposing genetic heart diseases…
Macitentan/Tadalafil Fixed Dose Combination reduces PVR compared with monotherapy
Key Points: Macitentan and Tadalfil are frequently used in combination for PAH,…
A Virtual Care Team-Guided Strategy Improved GDMT in Hospitalized HFrEF Patients: the IMPLEMENT-HF Study
Key Points Despite an extensive body of evidence supporting the benefit and…
Lifelong Endurance Not linked to Favorable Coronary Plaque Composition but Less Vulnerable ones: MASTER at HEART Trial
Key Points Cardiovascular risk mitigation strategies such as the recommendation to engage…
Treat-to-target LDL Strategy Non-inferior to High-Intensity Statin Therapy In CAD Patients: the LODESTAR trial
Key Points Appropriate lipid management is of critical importance in preventing further…
Black women with TTR V122I variant have higher risk of CVD and all-cause mortality
Key Points: The prognostic significance of the V122I variant (associated with…